The Role of MUC1 under Hypoxia in Pancreatic ductal adenocarcinoma

被引：0
|
作者：
Yokoyama, Seiya [1 ]
Higashi, Michiyo [1 ]
Tanimoto, Akihide [1 ]
机构：
[1] Kagoshima Univ, Dept Pathol Med & Dent Sci, Kagoshima, Japan
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3246
引用
收藏
页码：2111 / 2111
页数：1
相关论文
共 50 条
  • [21] Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas
    Yokoyama, Seiya
    Higashi, Michiyo
    Kitamoto, Sho
    Oeldorf, Monika
    Knippschild, Uwe
    Kornmann, Marko
    Maemura, Kosei
    Kurahara, Hiroshi
    Wiest, Edwin
    Hamada, Tomofumi
    Kitazono, Ikumi
    Goto, Yuko
    Tasaki, Takashi
    Hiraki, Tsubasa
    Hatanaka, Kazuhito
    Mataki, Yuko
    Taguchi, Hiroki
    Hashimoto, Shinichi
    Batra, Surinder K.
    Tanimoto, Akihide
    Yonezawa, Suguru
    Hollingsworth, Michael A.
    ONCOTARGET, 2016, 7 (27) : 42553 - 42565
  • [22] Expression of MUC1 and MUC4 in Gallbladder Adenocarcinoma
    Kim, Su-Mi
    Oh, Sun-Ju
    Hur, Bang
    KOREAN JOURNAL OF PATHOLOGY, 2012, 46 (05) : 429 - 435
  • [23] The significance of MUC1 and MUC2 expression and their relationship to clinical and pathologic parameters ipancreatic ductal adenocarcinoma.
    Adsay, V
    Siadety, MS
    Sarkar, F
    Frank, J
    Tabecska, P
    Koptcher, G
    Morati, K
    LABORATORY INVESTIGATION, 2001, 81 (01) : 191A - 191A
  • [24] Regulation of MUC1 by hypoxia is independent on HIF
    Mikami, Yuji
    Hisatsune, Akinori
    Isohama, Yoichiro
    Katsuki, Hiroshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 106P - 106P
  • [25] EGFR-mediated phosphorylation of MUC1 cytoplasmic tail in pancreatic adenocarcinoma cells
    Singh, Pankaj K.
    Cerny, Ronald L.
    Hollingsworth, Michael A.
    CANCER RESEARCH, 2006, 66 (08)
  • [26] Biphasic Alterations in Expression and Subcellular Localization of MUC1 in Pancreatic Ductal Carcinogenesis in Syrian Hamsters
    Kitahashi, Tsukasa
    Takahashi, Mami
    Imai, Toshio
    PANCREAS, 2015, 44 (01) : 76 - 86
  • [27] Clinical significance of MUC13 in pancreatic ductal adenocarcinoma
    Khan, Sheema
    Zafar, Nadeem
    Khan, Shabia S.
    Setua, Saini
    Behrman, Stephen W.
    Stiles, Zachary E.
    Yallapu, Murali M.
    Sahay, Peeyush
    Ghimire, Hemendra
    Ise, Tomoko
    Nagata, Satoshi
    Wang, Lei
    Wan, Jim Y.
    Pradhan, Prabhakar
    Jaggi, Meena
    Chauhan, Subhash C.
    HPB, 2018, 20 (06) : 563 - 572
  • [28] POSTTRANSLATIONAL PROCESSING OF MUC1 BY PANCREATIC TUMORS
    HOLLINGSWORTH, MA
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1994, 16 (2-3) : 258 - 259
  • [29] Immunity to MUC1 in pancreatic and breast cancer
    Geller, B. A.
    Lepisto, A. J.
    Ahrendt, G. M.
    Finn, O. J.
    Ramanathan, R. K.
    Brufsky, A. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance
    Sierzega, Marek
    Mlynarski, Damian
    Tomaszewska, Romana
    Kulig, Jan
    HISTOPATHOLOGY, 2016, 69 (04) : 582 - 591
12345